BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Viron Therapeutics Inc. 

UWO Research Park
700 Collip Circle, Suite 203
London  Ontario  N6G 4X8  Canada
Phone: 519-858-5109 Fax: 519-858-5103


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Viron Therapeutics Inc. Reports Positive Proof of Concept Results in Arthritis for its VT-346 Anti-TNF Therapeutic 3/16/2010 8:44:55 AM
Viron Therapeutics Inc. Granted U.S. Patents for Organ Transplant and Arthritis Drug Candidates 12/22/2009 9:02:49 AM
Viron Therapeutics Inc. to Present Data from Phase II Trial at American Heart Association Conference 11/12/2009 8:21:06 AM
Viron Therapeutics Inc. Appoints Claude Benedict, M.D. as New Senior Vice President, Clinical Development and Regulatory Affairs 5/1/2007 1:14:26 PM
Viron Therapeutics Inc. Signs Agreement With Diosynth Biotechnology For Clinical Manufacturing Of VT-111 10/25/2006 10:34:38 AM
Viron Therapeutics Inc. Signs Agreement With Diosynth Biotechnology For Clinical Manufacturing Of VT-111 10/24/2006 11:18:04 AM
Viron Therapeutics Inc.'s VT-111 Among Top 10 Most Promising Drugs 10/4/2006 2:16:20 PM
Viron Therapeutics Raises US $20 Million Series A Financing; Positions Viron To Complete Phase II Trial And Advance Additional Compounds Into Clinical Development 5/16/2006 10:32:43 AM
Viron Therapeutics Wins Prestigious 2005 Prix Galien Award 11/14/2005 11:27:55 AM
Viron Therapeutics Initiates Phase 2 Clinical Trial Of Novel Anti-Inflammatory For Acute Coronary Syndromes10/19/2005 5:12:47 PM
12